Abstract
Objective: To assess the impact of fetal exposure to cannabis on adiposity and glucose-insulin traits in early life. Research Design and Methods: We leveraged a subsample of 103 mother-child pairs from Healthy Start, an ethnically diverse Colorado-based cohort. Twelve cannabinoids/metabolites of cannabis (including Δ9-tetrahydrocannabinol and cannabidiol) were measured in maternal urine collected at ~27 weeks' gestation. Fetal exposure to cannabis was dichotomized as exposed (any cannabinoid>limit of detection [LOD]) and not exposed (all cannabinoids
Author supplied keywords
Cite
CITATION STYLE
Moore, B. F., Sauder, K. A., Shapiro, A. L. B., Crume, T., Kinney, G. L., & Dabelea, D. (2022). Fetal Exposure to Cannabis and Childhood Metabolic Outcomes: The Healthy Start Study. Journal of Clinical Endocrinology and Metabolism, 107(7), E2862–E2869. https://doi.org/10.1210/clinem/dgac101
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.